Results 51 to 60 of about 131 (70)

PEGylated therapeutics in the clinic. [PDF]

Bioeng Transl Med
Gao Y, Joshi M, Zhao Z, Mitragotri S.
europepmc   +1 more source

From guardians to traitors: molecular mechanisms of tumor-induced T cell betrayal. [PDF]

Mol Cancer
Ye P, Kuang H, Lin A, Tang B, Wang Q, Zhang H, Wong HZH, Zhang J, Cheng Q, Glaviano A, Yang T, Du H, Luo P.   +12 more
europepmc   +1 more source

Guided immunotherapy for residual solid tumor: integrating platelets and CAR T cells to reduce post-surgical recurrence. [PDF]

Biomark Res
Heydari F, Zendehdel H, Varkiani MM, Fahmi S, Derakhshani M, Anvari S, Farhid F, Hamblin MR, Naghinezhad J.   +8 more
europepmc   +1 more source

Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy. [PDF]

J Cell Physiol
Kumari S, Gupta S, Jamil A, Tabatabaei D, Karakashev S.   +4 more
europepmc   +1 more source

Plant amino acid analogues as antimicrobial agents. [PDF]

Amino Acids
Demash D, Stasyk O, Stasyk O.
europepmc   +1 more source

Neutrophils in the era of single-cell RNA sequencing: functions and targeted therapies in cancer. [PDF]

Cancer Biol Med
Qin J, Wei F, Ren X.
europepmc   +1 more source

Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery-A Humanitarian Cause. [PDF]

Int J Mol Sci
Niazi SK, Magoola M.
europepmc   +1 more source